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Professional mononuclear phagocytes such as polymorphonuclear neutrophils (PMN), monocytes, and macrophages are
considered as the first line of defence against invasive pathogens. The formation of extracellular traps (ETs) by activated
mononuclear phagocytes is meanwhile well accepted as an effector mechanism of the early host innate immune response acting
againstmicrobial infections. Recent investigations showed evidence that ETosis is a widely spread effectormechanism in vertebrates
and invertebrates being utilized to entrap and kill bacteria, fungi, viruses, and protozoan parasites. ETs are released in response to
intact protozoan parasites or to parasite-specific antigens in a controlled cell death process. Released ETs consist of nuclear DNA
as backbone adorned with histones, antimicrobial peptides, and phagocyte-specific granular enzymes thereby producing a sticky
extracellular matrix capable of entrapping and killing pathogens.This review summarizes recent data on protozoa-induced ETosis.
Special attention will be given to molecular mechanisms of protozoa-induced ETosis and on its consequences for the parasites
successful reproduction and life cycle accomplishment.
1. Introduction
Professional mononuclear phagocytes, such as polymorpho-
nuclear neutrophils (PMN), monocytes, and macrophages,
are considered as the first line of defence of the early host
innate immune response [1, 2]. Their main function has been
classically understood to kill invasive pathogens by a variety
of potent intracellular microbicidal effector mechanisms [3–
7]. After the first contact with pathogens, mononuclear
phagocytes engulf and internalize them into their phago-
somes. By the fusion with intracellular granules and the for-
mation of phagolysosomes the pathogensmay be killed intra-
cellularly by a combination of non-oxidative and oxidative
mechanisms [1, 8]. Actions of potent antimicrobial peptides,
such as defensins, cathelicidins, cathepsins, pentraxin, and
lactoferrin, are parts of non-oxidative killing mechanisms,
while oxidative killing relies exclusively on the production of
antimicrobial reactive oxygen species (ROS) via the NADPH
oxidase (NOX) complex [5].Within blood circulating phago-
cytes, PMN are by far the most abundant cell population
representing 50–80% of the total white blood cells in different
vertebrates [5]. Moreover, after being released from the bone
marrow into the blood circulation, PMN are highly mobile
and short-lived phagocytes, being densely packed with secre-
tory granules [4, 8]. PMN granules are categorized into three
different types based on their contents: primary (azurophilic),
secondary (specific), and tertiary (gelatinase) granules. The
types of granules to be found in circulating PMN depend
on their maturation stage.Thus, PMNmaturation starts with
the formation of primary granules, followed by secondary
and tertiary granules [4, 9, 10]. The content of primary gran-
ules includes myeloperoxidase (MPO), neutrophil elastase
(NE), cathepsin G, proteinase 3, defensins, and lysozyme;
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secondary granules contain collagenase, gelatinase, cystatin,
lysozyme, and lactoferrin; and tertiary granules comprise
gelatinase, lysozyme, and arginase amongst others [10]. Fol-
lowing granule maturation, PMN will possess all three types
of granules displaying full killing capacity not only in the
blood but also in tissues/organs and gut lumen [10].
In addition, PMN act against pathogens by actively
participating in complex inflammatory networks such as the
release of a broad panel of proinflammatory chemokines,
cytokines, and survival- and growth-factors which trigger
both downstream proinflammatory effects and the transition
into adaptive immune reactions. As such, several proin-
flammatory cytokines/chemokines were found enhanced in
activated PMN in response to apicomplexan parasites, such
as TNF-𝛼, IL-1𝛽, CC, and CXC chemokines (e.g., IL-8, IP-
10, GRO-𝛼, RANTES, and MIP-1𝛼) [11–15]. Several of PMN-
derived immunomodulatory molecules can augment the
production of various chemokines and cytokines to further
regulate phagocyte functions [16, 17]. More importantly, by
this means activated PMN recruit not only other innate
immune cells but also T cells to the site of infection [18–20]
or even induce sterile inflammation [21, 22].
2. Neutrophil Extracellular Traps (NETs) and
Phagocyte-Derived Extracellular Traps (ETs)
Beginning with the landmark study of Brinkmann et al. [31],
the paradigm of how PMN fight and kill pathogenic bacteria
has profoundly been changed. The discovery of DNA-based
antimicrobial neutrophil extracellular traps (NETs) changed
the current knowledge on innate immune reactions not
only on the level of the pathogen killing but also on the
pathophysiology of metabolic, autoimmune, reproductive,
and inflammatory diseases, as well as cancer progression [32–
37]. NETs are released by activated PMN by a novel cell death
process, called NETosis [38], which can be stimulated by a
variety ofmolecules and invasive pathogens.Microorganisms
such as bacteria [31, 39–41], fungi [42–44], viruses [45–
49], and parasites [50–55] were identified as NET inducers.
Also different molecules or cellular structures such as GM-
CSF/complement factor 5a [56, 57], activated platelets [40,
58], PMA and zymosan [24, 26, 31, 59], singlet oxygen
[60], LPS [31, 61], and Fc receptor [42] trigger NETosis. In
addition, IL-8 as well-known chemoattractant for PMN was
demonstrated as NET inducer [31, 62]. Efficient NETosis
requiresmature PMNand inmost cases NOX,MPO,NE, and
peptidylarginine deiminase type IV (PAD4) activities [14, 24,
59, 63–65]. Furthermore, the process of NETosis obviously
requires intracellularly signalling pathways of which Raf-
MEK-ERK kinases as well as p38 MAPK are being the most
frequently reported to be involved in this process [14, 23, 33,
66–69]. In addition, calcium release is needed for optimal
NET formation in different vertebrate species [14, 23, 70–
72]. Upon stimulation of PMN, the nuclear envelope disin-
tegrates permitting the mixture of chromatin with granular
proteins/peptides [38]. NE and MPO degrade histones (H1,
H2A/H2B, H3, and H4) and promote chromatin decon-
densation [65], mediated by PAD4 via hypercitrullinating
of specific histones to allow electrostatic coiling of the
chromatin [64, 73, 74]. The total of the DNA complexes
being decorated with granular proteins/peptides and specific
histones (H1, H2A/H2B, H3, and H4) are finally extruded as
NETs to the extracellular environment by dying PMN.
NET formation is primarily a NOX-dependent mech-
anism [14, 24, 59, 75, 76]. However, NOX-independent
NETosis was also reported [29, 60, 67, 68, 77]. This mode
of NETosis is accompanied by a substantially lower level of
ERK activation and rather moderate level of Akt activation,
whereas activation of p38 is similar in both kinds of NET for-
mation [67, 68]. As an example, singlet oxygen can stimulate
NETosis in a NOX-independent manner [60]. Irrespectively
of NOX-dependency, pathogens may either be immobilised
within sticky DNA fibres [55, 78, 79] or be killed via the local
high concentration of effector molecules [31, 42, 51, 53].
Meanwhile, other types of leukocytes of the innate
immune system, such as macrophages [80–83], monocytes
[26, 28], mast cells [84, 85], eosinophils [55, 86, 87], and
also basophils [88], have been reported to release NET-like
structures which are now collectively entitled as extracellular
traps (ETs).
Interestingly,Malawista et al. [89] described alreadymany
years ago that enucleated PMN may remain vital and are
even capable of killing invasivemicrobes.More recent studies
corroborated these findings proving that leukocytes do not
necessarily die after ET extrusion [56, 68, 86]. In this context,
Yousefi et al. [56, 86] demonstrated that eosinophils and
certain PMN subpopulations release ETs of mitochondrial
origin without dying. Furthermore, Yipp et al. [90] verified
that PMN which had released NETs were still viable and
retained their capability to engulf bacteria via phagocytosis.
TheprecisemechanismofNOX-independentNET formation
is not clear yet. However, it appears to be nonlethal for PMN
and faster than NOX-dependent NET formation and to rely
on a vesicular-based pathway releasing nuclear DNA [33, 68].
Additionally, different molecular pathways will lead in
a stimulus-dependent manner to the extrusion of different
types of ETs in vitro and in vivo. Different morphological
forms of ETs were for the first time described in the human
gout disease in vivo proving that monosodium urate crys-
tals (MSU) induced aggregated (aggETs), spread (sprETs),
and diffused (diffETs) ET formation [91]. Consistently, also
parasite-mediated ETosis resulted in different types of ETs.
As such, the parasitic nematodeHaemonchus contortus larvae
triggered in ruminant PMN and eosinophils aggETs, spreETs,
and diffETs [55].
3. Apicomplexan Protozoa-Induced Formation
of NETs and ETs
3.1. Plasmodiidae. While most NET- and ET-related studies
focused on bacterial, viral, and fungal pathogens, little atten-
tion was paid to protozoan parasites. As such, the first ever
published study on parasite-triggered NETosis was published
in 2008 by Baker et al. [50] 4 years after the discovery of this
novel effector mechanism [31] and reported on Plasmodium
falciparum-triggered NET formation.
Mediators of Inflammation 3
Plasmodium spp. parasites aremosquito-borne pathogens
that cause malaria, a serious public health disease worldwide
in the tropic and subtropics. Globally, an estimated 3.3
billion people are at risk of being infected with malaria of
whom approximately 1.2 billion are at high risk (>1 in 1000
chance) of developing malarial disease [92]. The first report
on P. falciparum-induced NETs referred to P. falciparum-
infected children and demonstrated in vivo NET-entrapped
trophozoite-infected erythrocytes in blood samples [50].
Moreover, Baker and colleagues [50] provided first evi-
dence on the involvement of parasite-triggered NETs in the
pathogenesis of malaria since the high levels of anti-dsDNA
antibodies were above the predictive levels for autoimmunity.
Interestingly, a recent study also indicates the capacity of
P. falciparum to inhibit NET formation [93] which may
be of relevance in immunopathogenesis. Thus, a mosquito-
derived salivary protease inhibitor (agaphelin) induced by P.
falciparum infection inhibited vertebrate elastase and NET
formation [93]. Whether this represents a true anti-NET
mechanism remains to be elucidated.
3.2. Eimeriidae. Parasites of the genus Eimeria are worldwide
of high veterinary and economic importance in livestock,
especially in chicken [94], cattle and small ruminants [95–
100]. Coccidiosis is a disease with high morbidity in animals
of all ages, nonetheless inducing pathogenicity especially in
young animals [101] and occasionally causing death of heavily
infected animals [99, 102, 103].
Several studies showed that PMN infiltrate intestinal
mucosa in response toEimeria infections and are occasionally
found in close contact to the parasitic stages in vivo [102, 104–
107]. PMN have also been shown to directly interact with
E. bovis stages and antigens in vitro, resulting in release
of proinflammatory cytokines, chemokines, and iNOS [13].
Additionally, their phagocytic and oxidative burst activities
were enhanced in response to Eimeria stages in vitro and in
vivo [13]. First indications on Eimeria spp. as potent NET
inducers came from Behrendt and colleagues who reported
on sporozoites to be entangled by an extracellular network of
delicate DNA fibres being extruded from PMN in vitro (Fig-
ure 1(a)) [52]. Using extracellular DNA measurements and
DNase treatments the authors presented strong indications
that these structures were NETs. Other studies confirmed
typical characteristics of NETs, such as the colocalization of
NE, MPO, and histones in the DNA backbone of Eimeria-
induced NET-like structures [23]. Meanwhile, also other
pathogenic ruminant Eimeria species were shown to induce
NETosis, such as E. arloingi (Figures 2(a) and 2(b)) [24, 27]
and E. ninakohlyakimovae (Pe´rez, personal communication).
Importantly, Mun˜oz-Caro and colleagues proved NETs also
to occur in vivo in Eimeria-infected gutmucosa [27].The cur-
rent data suggest that Eimeria-induced NETosis is a species-
and stage-independent mechanism, since it was induced by
sporozoites, merozoites I, or oocysts of different Eimeria
species [23, 24]. Given that PMN were described to act even
in the intestinal lumen via different effector mechanisms [27,
108, 109], it appears likely that interactions of luminal PMN
with ingested Eimeria oocysts or newly excysted sporozoites
may occur [6, 23, 24]. In particular, NET-related reactions
against oocysts would have a high impact on the ongoing
infection since they may hamper proper excystation of
infective stages (sporozoites) and, in consequence, dampen
the degree of infection at the earliest possible time point
in the host. Since E. arloingi sporozoites must egress from
the oocyst circumplasm through the micropyle [24], NETs
covering this area of the oocyst will have a detrimental
effect on proper excystation [6, 24]. The same explanation
seems feasible for E. bovis and E. ninakohlyakimovae, regard-
less of the fact that excystation occurs by rupture of the
oocyst walls prior to sporozoites egress from sporocysts.
Although all Eimeria species tested so far equally induced
NETs, significant differences in entrapment effectivity were
reported amongst different host species, parasite species, and
stages. Thus, caprine NETs immobilised a high proportion
of E. arloingi sporozoites (72%) [24], whilst in the bovine
system considerably less parasite stages (E. bovis sporozoites:
43%, B. besnoiti tachyzoites: 34%) were found entrapped in
NET structures [23, 59]. So far, it remains to be elucidated
whether the varying effectivity of NETs is based on the PMN
origin (goats are generally considered as strong immune
responders) or on the parasite species.
The molecular basis of Eimeria-induced NETosis is not
entirely understood, so far. Enzyme activity measurements
and inhibition studies revealed a key role of NOX, NE,
and MPO in Eimeria-triggered NET formation (see Table 1)
which is in agreement to bacterial, fungal, and parasitic
pathogens [14, 25, 59, 65, 75, 110]. Referring to signal cascades,
analyses on the grade of phosphorylation revealed a key role
of ERK1/2 and p38 MAPK in sporozoite-exposed bovine
PMN. Since respective inhibitor experiments led to decreased
parasite-mediated NET formation, Mun˜oz-Caro et al. [23]
proved the relevance of this signalling pathway in sporozoite-
triggered NETosis. This finding is in agreement with data
on T. gondii-mediated NET formation [25]. Referring to
Ca2+ influx, further inhibition experiments proved E. bovis-
mediated NETosis as dependent on intracellular Ca2+ mobi-
lization, since 2-ABP (inhibitor of store-operated Ca2+ entry)
[23] and BAPTA-AM (binding intracellular Ca2+; Mun˜oz-
Caro, unpublished data) but not EGTA (inhibitor of Ca2+
influx from the extracellular compartment; Mun˜oz-Caro,
unpublished data) significantly blocked parasite-triggered
NETosis. So far, little is known on PMN-derived receptors
mediating parasite-triggered NETosis. Mun˜oz-Caro et al.
[23] reported on enhanced CD11b surface expression on
PMN following E. bovis sporozoite exposure. By antibody-
mediatedCD11b blockage leading to a significant reduction of
parasite-triggered NETosis, the authors proved the relevance
of this receptor in the NET formation process.
Bacteria and fungi NETosis was reported as a lethal
effector mechanism [31, 42]. However, killing effects of
NETs were not observed in the case of Eimeria spp. so
far. Given that Eimeria spp. are obligate intracellular par-
asites, the main function of NETs rather seems to be the
extracellular immobilisation of infective stages hampering
them from host cell invasion. Accordingly, reduced host cell
infections rates were reported for E. bovis and E. arloingi
sporozoites when previously exposed to PMN [23, 24].
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 1: ETosis is not a parasite- nor a stage-specific cell death process (SEManalysis). (a)Eimeria bovis sporozoite-triggered bovineNETosis;
(b)Cryptosporidiumparvum oocysts (back arrows) inducedNETosis (white arrows); (c)Toxoplasma gondii tachyzoites entrapped by a delicate
DNA fibre derived from bovine PMN; (d) Toxoplasma gondii tachyzoite completely entrapped in filigree NET structures; (e) PMN-derived
NETs (white arrow) after Besnoitia besnoiti tachyzoites encounter (black arrows); (f) Neospora caninum tachyzoites (black arrow) trapped in
bovine NETs (white arrow); (g) monocyte-derived extracellular traps (METs) forming spread (white arrow) ETs entrapping Besnoitia besnoiti
tachyzoites (black arrow); (h) Besnoitia besnoiti derived thick and thin METs.
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(a) (b)
Figure 2: Colocalization of caprine NET-derived DNA and MPO. (a) Cocultures of caprine PMN and Eimeria arloingi sporozoites (blue
arrows) were fixed, permeabilized, stained for DNA using Sytox Orange, and probed forMPO using anti-MPO along with adequate conjugate
systems (white arrows); (b) cocultures of caprine PMN exposed to sporulated E. arloingi-oocysts (red arrows) and sporozoites (blue arrows).
Filigree spread NET structures are indicated by white arrows. Bar scale = 20𝜇m.
The same feature was reported for monocyte-preexposed
E. bovis sporozoites indicating that this leukocyte cell type
also casts ETs in response to this parasite stage and that
ETosis had an impact on parasite invasion [28]. Besides
E. bovis [59], E. arloingi (Silva, unpublished data), and
E. ninakohlyakimovae (Pe´rez et al., submitted manuscript)
were also shown to induce monocytes-derived ETs. Fur-
thermore, E. ninakohlyakimovae-induced monocytes-ETosis
showed a rapid induction of ETs release upon viable sporo-
zoites, sporocysts, and oocysts encounters, corroborating
a stage-independent process in monocyte-derived ETosis.
In addition, it was found that caprine monocyte-derived-
ETosis is NOX-dependent. With the upregulation of the
genes transcription encoding for IL-12 and TNF-𝛼, relevant
immunoregulatory cytokines with transition properties into
the adaptive immunity [111] were also demonstrated in E.
ninakohlyakimovae-exposed caprine monocytes (Pe´rez et al,
submitted manuscript).
Since the reduction in infection rates early after infection
automatically results in decreased proliferation of the para-
site, this indirect ET-mediated effect should have a beneficial
impact on the outcome of the disease. Despite advantageous
properties of ETs, their ineffective clearance and/or poor
regulation might also bear adverse pathological implications,
leading to tissue damage in addition to enhanced local
proinflammatory reactions [112, 113].
3.3. Sarcocystidae. Toxoplasmosis is caused by the facultative
heteroxenous apicomplexan polyxenous protozoan T. gondii
representing one of the most common parasitic zoonoses
worldwide [114]. Toxoplasma gondii is well known to affect
almost all warm-blooded mammals including a wide range
of domestic animals, wild mammals, marine mammals,
marsupials, and humans [115, 116]. In response to T. gondii
infections, PMN are promptly recruited to the site of infec-
tion producing a variety of proinflammatory cytokines and
chemokines [11, 117]. In addition, PMN are capable of killing
T. gondii tachyzoites via phagocytosis [118, 119]. Besides this
effector mechanism, human, murine, bovine, and harbour
seal (Phoca vitulina) PMN additionally perform NETosis
in reaction to T. gondii tachyzoites (Figures 1(c) and 1(d))
[25, 26]. Abi Abdallah et al. [25] showed that NETosis was
triggered by tachyzoites in a parasite strain-independent fash-
ion as an invasion/phagocytosis-independent process. Inter-
estingly, in the murine toxoplasmosis model, tachyzoites-
induced NETs were not the result of a random cell lysis,
but of a controlled DNA release process since lysozyme was
still present in PMN after performing NETosis [25, 120].
In contrast to Eimeria spp., T. gondii-triggered NETosis
had modest toxoplasmacidal effects by killing up to 25% of
the parasites [25]. Considering the obligate intracellular life
style of T. gondii and its enormous proliferative capacity in
mammalian host cells, parasite entrapment via NETs might
be of particular importance in vivo based on its interference
with host cell invasion. Consistently, harbour seal PMN-
promoted NETs significantly hampered host cell invasion
of T. gondii tachyzoites in vitro [26]. In vivo evidence of T.
gondii-inducedNETosis was reported in amurine pulmonary
infection model, revealing an increase of dsDNA contents
in the bronchoalveolar lavage fluids of T. gondii-infected
mice [25]. As equally reported for several other coccidian
parasites [14, 23], T. gondii-induced NETs were also proven
to be NOX-, NE-, MPO-, and Ca2+- (SOCE) dependent and
to be mediated by an ERK 1/2-related signalling pathway in
PMN (see Table 1) [25, 26]. Additionally, in earlier studies,
not only the pivotal role of PMN but also the important
role of monocytes in toxoplasmosis was clearly demonstrated
[121–123]; however, their capacity to also induce ETs in
response to tachyzoite stages was just recently demonstrated
[26]. Exposure of harbour seal-derived monocytes to viable
T. gondii tachyzoites resulted in a significant induction of
monocyte-ETs and tachyzoites were firmly entrapped and
immobilised within harbour seal monocyte-ET structures,
hampering parasite replication [26].
Bovine besnoitiosis caused by Besnoitia besnoiti is an
endemic disease in Africa and Asia [124–126] and considered
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Table 1: List of apicomplexan and euglenozoan protozoa capable of inducing ETosis, host species, professional phagocytes triggering ETs,
and molecular mechanisms involved in this cell death process.
Parasites Host species Professionalphagocytes ETosis dependency References
Eimeria bovis Bovine PMN
NOX
NE
MPO
CD11b
ERK 1/2
p38 MAPK
SOCE
Mun˜oz-Caro et al. [23]
Eimeria arloingi Caprine PMN NOX Silva et al. [24]
Eimeria ninakohlyakimovae Caprine PMN NOX Pe´rez et al. (submitted manuscript)
Monocytes NOX Pe´rez et al. (submitted manuscript)
Toxoplasma gondii
Mouse PMN ERK 1/2 Abi Abdallah et al. [25]
Harbour seal PMN
NOX
NE
MPO
SOCE
Reichel et al. [26]
Besnoitia besnoiti
Bovine PMN
NOX
NE
MPO
Mun˜oz-Caro et al. [27]
Bovine Monocytes NOXMPO Mun˜oz-Caro et al. [28]
Neospora caninum Bovine PMN
NOX
NE
MPO
ERK 1/2
p38 MAPK
SOCE
P2Y2
PAD4
Villagra-Blanco et al. (submitted manuscript)
Cryptosporidium parvum Bovine PMN
NOX
NE
MPO
ERK 1/2
p38 MAPK
SOCE
Mun˜oz-Caro et al. [14]
Leishmania spp. Human PMN
NOX
NE
PAD4
Rochael et al. [29]
Trypanosoma cruzi Human PMN
NOX
TLR2
TLR4
Sousa-Rocha et al. [30]
as emergent in Europe [127]. During the acute phase of
cattle besnoitiosis, B. besnoiti tachyzoites mainly replicate
in host endothelial cells of different organs [28, 128] and,
upon release, may be exposed to circulating leukocytes.
Besnoitia besnoiti tachyzoites were recently reported as effec-
tive inducers of PMN- and monocyte-derived ETs (Figures
1(e), 1(g), and 1(h)) [28, 59]. In the latter case, ETosis was
further reported to occur as an invasion- and phagocytosis-
independent process [28]. A high proportion of PMN was
found to be involved in NETosis, since up to 76% of
encountered PMN were found to participate in NETosis
leading to the immobilisation of approximately one-third
of the parasites [59]. Besnoitia besnoiti-triggered NETosis
furthermore proved as vitality-independent process that was
even induced by soluble parasite molecules (homogenates),
though at lower levels [59]. Regarding PMN-derived effector
molecules, NOX, NE, and MPO proved as essential for
efficient B. besnoiti-triggered NETosis [59]. Thus, respective
enzyme activities were encountered in tachyzoite-exposed
PMN and chemical blockage of these enzymes via inhibitors
blocked parasite-triggered NETosis [28, 59]. In contrast to
tachyzoites ofT. gondii, entrappedB. besnoiti tachyzoites were
neither killed by NETs nor ETs since their host cell infectivity
was entirely restored upon DNase I treatments [28, 59].
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Given that B. besnoiti tachyzoites mainly proliferate
within endothelial cells during the acute phase, these par-
asitic stages are released via cell lysis in close proximity to
endothelium and are exposed to blood contents, such as
leukocytes. Several reports have shown that NETs them-
selves interact with endothelium and may cause endothelial
damage or dysfunction [129–131]. Since activated endothelial
cells may produce a broad panel of immunomodulatory
molecules with IL-8 or P-selectin having been identified as
potentNET inducers [129, 132], interactions between infected
endothelial cells, B. besnoiti tachyzoites, and NETs are quite
likely. Accordingly, Maksimov et al. [15] recently reported on
infection-induced upregulation of endothelial-derived IL-8
and P-selectin gene transcription and furthermore presented
indications on NET formation occurring adjacent to infected
endothelium after PMN adhesion assays being performed
under physiological flow conditions as the ones present in
small vessels.
Recent NET-related investigations on the closely related
cyst-forming apicomplexan protozoaNeospora caninum have
shown that bovine PMN exposed to viable tachyzoites
also result in strong NETosis (Figure 1(f)). With regard
to molecular mechanisms, N. caninum-triggered NETosis
seems to be P2Y2-, NOX-, SOCE-, MPO-, NE-, ERK1/2-,
p38 MAPK-, and PAD4-dependent (Villagra-Blanco et al.,
submitted manuscript).
3.4. Cyptosporiidae. Cryptosporidium parvum is an euryxe-
nous apicomplexan parasite with worldwide distribution
and high zoonotic potential, mainly affecting young chil-
dren, immunocompromised humans, and neonatal livestock
[133]. Typically, cryptosporidiosis is a water- and food-borne
enteric disease that causes diarrhoea, dehydration, weight
losses, and abdominal pain and leads to significant economic
losses in the livestock industry [133, 134]. After ingestion,
sporozoites are released from oocysts into the intestinal
lumen and infect small intestine epithelial cells [135]. Recent
studies reported on a significant contribution of PMN and
macrophages to inflammatory responses in cryptosporidiosis
in vivo [136, 137]. Mun˜oz-Caro and colleagues reported on
NETs being cast by both bovine and human PMN in response
to C. parvum stages [14]. Parasite-triggered NETosis proved
stage-independent since it was induced by both sporozoites
and oocysts (Figure 1(b)). Especially in the latter case parasite
stages were occasionally entirely coveredwithNET structures
therebymost probably hampering proper sporozoite excysta-
tion [14]. Given that PMN were shown as active even within
the intestinal lumen [108, 109, 138, 139], these reactions should
have a significant impact on ongoing in vivo infection. In
vitro infection experiments additionally showed the negative
impact of NETs on host cell invasion since infection rates
were significantly reduced when using PMN-preexposed C.
parvum stages [14].The fact that these reactions were entirely
reversible via DNase I treatments rather argued against
any cryptosporidicidal effects of NETs [14]. The colocal-
ization of NE, histones, and MPO with DNA in parasite-
mediated extracellular fibres proved classical characteristics
of NETs and inhibitor experiments emphasized the key role
of NE, NOX, and MPO in efficient NET formation [14].
In agreement with findings on Eimeria-induced NETosis,
inhibition experiments revealed C. parvum-triggered NET
formation as dependent on intracellular Ca2+ release and
ERK 1/2 and p38 MAPK-mediated signalling pathways [14].
Interestingly, C. parvum sporozoite-exposed bovine PMN
showed increased gene transcription of proinflammatory
molecules, some of which were recently shown as potent
NET inducers (e.g., IL-8 and TNF-𝛼) [140, 141] and may have
potentiated NET reactions.
4. Euglenozoan Protozoa-Induced NETs
4.1. Trypanosomatidae. Infections with Leishmania spp. rep-
resent a major health problem and according to the WHO
[92] 10%of the humanworld population is at risk of infection,
meaning that approximately 12million people in 98 countries
are infected, and 2 million new cases occur each year [142,
143]. Leishmaniasis is a vector-transmitted zoonosis caused
by more than 25 different obligate intracellular protozoan
Leishmania species [142–144]. Particularly PMN have been
implicated in the immunopathogenesis of leishmaniasis [145–
149] and recent studies examined the potential role of NETs
during the early phase of the disease of different Leishmania
species. Guimara˜es-Costa et al. [51] showed for the first time
that promastigotes of Leishmania amazonensis, L. major, and
L. chagasi were capable of triggering NET formation. Addi-
tionally, Leishmania-triggered NETosis seems not entirely
stage-specific, since both promastigotes (L. amazonensis, L.
major, L. chagasi, L. donovani, L. mexicana, and L brasiliensis)
and amastigotes (L. amazonensis, L. braziliensis) promoted
NET formation in vitro and in vivo [51, 147, 150–152]. More
importantly, Guimara˜es-Costa et al. [51] provided first indi-
cations on possible parasite-specific ligands being responsible
for Leishmania-mediatedNETosis.Thus, Leishmania-derived
lipophosphoglycans (LPG)were suggested as themain trigger
of NET release since these molecules also induced NETs
in a purified form. The former authors showed that NETs
possessed detrimental effects on parasites as NET-entrapped
L. amazonensis promastigotes exhibited decreased viability
[51]. Authors also demonstrated that the extracellular DNA
and histones found on NETs were involved in the parasite
inactivation/killing process [51]. The leishmanicidal effects
of histones were proven in promastigotes cocultures with
purified H2A histones leading to the killing of parasites
and by a significant reduction of leishmanicidal effects
when cocultured in the presence of anti-histone antibodies.
Additionally to H2A histone killing effects, Wang et al. [153]
demonstrated that also the histone H2B could directly and
efficiently kill promastigotes of L. amazonensis, L. major, L.
braziliensis, and L. mexicana.
In case of L. donovani, Gabriel et al. [150] reported NETo-
sis as a ROS-dependent process which was equally triggered
in human andmurine PMN (see Table 1). However, Leishma-
nia-lipophosphoglycan- (LPG-) dependent NET induction
reported by Guimara˜es-Costa et al. [51] was not observed
with L. donovani. When using genetically modified L.
donovani promastigotes Gabriel et al. [150] observed a
lipophosphoglycan- and GP63-independent (promastigote
surface metalloprotease) NETosis pathway. Nonetheless, in
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this infection system, LPG appeared to be involved in the
resistance to NETs-mediated killing, since the wild type of
L. donovanimaintained its viability in the presence of NETs,
whilst mutant parasites lacking LPG were efficiently killed by
these extracellular structures [150].
A more recent study revealed that Leishmania para-
sites trigger not only the classical ROS-dependent NETosis
as previously demonstrated but also a ROS-independent
form, named as early/rapid vital NETosis [29]. During this
early/rapid Leishmania-triggered NETosis, in which NET
formation takes place after 5–15min of activation without
affecting PMN viability [29, 68], the parasites are also being
efficiently entrapped.
Regarding NET-related evasion strategies of Trypanoso-
matidae parasites, Leishmania spp. seem capable of evading
NET killing by firstly blocking the oxidative burst activ-
ity of PMN or even by resisting microbicidal activity of
NETs [145, 150]. Moreover, Guimara˜es-Costa et al. [152]
showed that L. infantum promastigotes express the enzyme
3󸀠-nucleotidase/nuclease which was previously described to
be involved in parasite nutrition and infection and was
proven to be part of the ability of promastigotes to escape
NET-mediated killing. A recent investigation has shown
that a salivary component of the sand fly insect that trans-
mits leishmaniasis may also play a role in the survival
of Leishmania in the definitive hosts, by modulating their
innate immune system. A molecule named Lundep from
the salivary gland of Lutzomyia longipalpis was recently
described as an endonuclease with NET-destroying prop-
erties in humans [145]. In the presence of Lundep, human
NETs were disrupted, thus increasing L. major survival rates
[145]. Furthermore, Chagas et al. [145] measured the NE
release from NETs as an indicator of NET destruction,
since NE is normally decorating NETs backbone structures
and found at low concentrations in culture supernatants, as
previously demonstrated [39]. Lundepwas responsible for the
significant increase of NE concentration in the supernatants
when compared to negative controls [145]. In conclusion,
these experiments showed degradation of DNA scaffold of
NETs, destroying their functional integrity, and increasing
promastigote survival and exacerbating L. major infection.
American trypanosomiasis or Chagas disease is caused
by the protozoan parasite Trypanosoma cruzi. Approximately
eight million people are affected by this tropical disease in
the Americas and an average of 12,000 deaths per year is
known to occur due to American trypanosomiasis [154]. It
is well known thatmacrophages, eosinophils,monocytes, and
PMN are implicated in the control of early infection [30, 155].
Recently, Sousa-Rocha et al. [30] demonstrated in vitro that
T. cruzi is able to trigger NETs in a dose-, time-, and ROS-
dependent manner. In agreement with reports on Eimeria
spp. and B. besnoiti [23, 24, 59] but in contrast to observations
on T. gondii and Leishmania spp. [25, 51], the viability
of T. cruzi stages was not affected by NETs, but NETosis
significantly impaired the parasite host cell infectivity. In fact,
NETs components as NE may affect T. cruzi infectivity, since
this enzyme appears to be involved in increased trypanocidal
activity and in the reduction of trypomastigote release by
prestimulated infected macrophages [30, 156]. Additionally,
the authors showed via antibody-mediated blockage that T.
cruzi-triggered NETosis is a TLR2- and TLR4-dependent
process. Moreover, the study showed that not only viable
T. cruzi trypomastigote forms but also soluble antigens and
killed T. cruzi parasites induced NET release in human PMN.
In vivomurine studies indicated the relevance of NETosis for
the outcome of trypanosomiasis since significantly decreased
parasites numbers were found in the blood system of those
animals which had previously been infected with NETs-
pretreated parasites [30].
5. Conclusions
During the last years a vast amount of data on protozoan-
mediated ETosis was published strengthening the role of this
effector mechanism in the defence of parasitic infections.
Several in vivo data have now proven the existence and
importance of this early host innate effector mechanism.
However, there is still a total lack of information on parasite-
derived ligands triggering ETosis. Taking into account that
in most cases ET formation is considered as a species-
and stage-independent process, rather ubiquitary occurring
molecules may represent parasite-derived target molecules
of ETs. Moreover, recent data revealed that other leukocytes
such as monocytes, macrophages, basophils, mast cells, and
eosinophils also perform ETosis upon pathogen encounter.
However, respective data on parasite-inducedmechanism are
scarce. Furthermore, ET-related research mainly focused on
the leukocytes aptitude to impact the parasites life cycle, but
not on the propensity of parasitic stages to develop counter
mechanisms for ETs avoidance. While a bunch of data is
available on bacterial nucleases or other countermechanisms,
parasites have been neglected on this topic. Taken together,
we call for more parasite-related studies in the exciting field
of ETosis.
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